Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a patient with CMT
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Mutations in the MFN2 gene are associated with Charcot-Marie-Tooth disease type 2A (CMT2A), a dominant axonal CMT, whereas mutations in GDAP1 are associated with recessive demyelinating CMT (CMT4A), recessive axonal CMT (AR-CMT2), and dominant axonal CMT (CMT2K). Both proteins are involved in energy metabolism and dynamics of the mitochondrial network.1,–,3 We have previously reported that, in fibroblasts from patients with CMT, MFN2 mutations resulted in a mitochondrial energy coupling defect,4,5 whereas dominant mutation in GDAP1 resulted in defective complex I activity.6
In this study, we investigated mitochondrial bioenergetics from a severely affected patient with CMT harboring combined mutations in both GDAP1 and MFN2 genes.
Methods.
For details, see e-Methods on the Neurology® Web site at www.neurology.org.
Patients.
Patient II-5 (figure 1A), a 71-year-old woman of Spanish origin, had severe distal muscle weakness from the age of 3, becoming wheelchair-bound during her third decade. Clinical examination showed severe weakness of limbs with proximal and distal amyotrophy, tactile and nociceptive hypoesthesia with a gloves-and-socks distribution, and abolition of the limb reflexes. She had pes cavus and moderate vocal cord paresis. Electrophysiologic studies (table e-1) indicated a severe axonal neuropathy characterized by a …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth diseaseAndrea Cortese, Janel E. Wilcox, James M. Polke et al.Neurology, December 11, 2019 -
Article
Genetic Survey of Autosomal Recessive Peripheral Neuropathy Cases Unravels High Genetic Heterogeneity in a Turkish CohortAyşe Candayan, Arman Çakar, Gulshan Yunisova et al.Neurology: Genetics, August 31, 2021 -
Articles
Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth diseaseRobert D.S. Pitceathly, Sinéad M. Murphy, Ellen Cottenie et al.Neurology, August 29, 2012 -
Article
Charcot-Marie-Tooth diseaseGenetic and clinical spectrum in a Spanish clinical seriesRafael Sivera, Teresa Sevilla, Juan Jesús Vílchez et al.Neurology, September 27, 2013